Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room - Transparency notification FMR LLC

INFORMATION REGLEMENTEE


[05/08/2022 | 20:05]
https://mb.cision.com/Public/18595/3610818/b8115ff58f13dacd_800x800ar.png

** Transparency notification FMR LLC
------------------------------------------------------------

Brussels (Belgium), 5 August 2022 =E2=80=93 20:05 (CEST) =E2=80=93 Regulate=
d information

1. Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB=C2=A0SA/NV announces that it received a transparency not=
ification from FMR LLC. (having its registered office at The Corporation Tr=
ust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19=
801, U.S.A.) on 3 August 2022.

FMR LLC., notified that, following a disposal of UCB=C2=A0shares with votin=
g rights by its affiliates, the shareholding in UCB SA/NV of a controlled e=
ntity decreased and crossed downwards the 3% threshold, on 1 August 2022.

On 1 August 2022, FMR LLC. (taking into account the holding of its affiliat=
es) owned 7 509 016 UCB=C2=A0shares with voting rights, representing 3.86% =
of the total number of shares issued by the company (194 505 658), versus 4=
.99 % (9 698 901 UCB shares) in the previous notification dated 24 May 2022=
.

2. Content of the notification

=C2=B7 Reason for the notification: Acquisition or disposal of voting secur=
ities or voting rights.
=C2=B7 Notification by: A parent undertaking or a controlling person.
=C2=B7 Persons subject to the notification requirement:

https://mb.cision.com/Public/18595/3610818/abf09884c5075e09_800x800ar.png

=C2=B7 Date on which the threshold is crossed: 1 August 2022.
=C2=B7 Threshold crossed (in %): 3%.
=C2=B7 Denominator: 194 505 658.
=C2=B7 Notified details:

https://mb.cision.com/Public/18595/3610818/b07ffbdadf650483_800x800ar.png

=C2=B7 Chain of controlled undertakings through which the holding is effect=
ively held:

=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=
=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8Bhttps://mb.cision.com/Pu=
blic/18595/3610818/817e4c5acee4c837_800x800ar.png

=C2=B7 Additional information: The holdings attributed to the entities ment=
ioned in heading 10 arise from holdings of various undertakings for collect=
ive investment that are managed by FIAM LLC, Fidelity Institutional Asset M=
anagement Trust Company, Fidelity Management & Research Company LLC, Fideli=
ty Management Trust Company, FMR Investment Management (UK) Limited and Str=
ategic Advisers LLC each of which are entities that are subsidiaries of and=
controlled by FMR LLC. The entities mentioned in heading 10 are the discre=
tionary investment managers and exercise the voting rights at their discret=
ion in the absence of specific instructions. Threshold crossed by a Control=
led Undertaking.

3. Further information

This press release and the detailed transparency notification are available=
on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://www.uc=
b.com/investors/UCB-shareholders/Transparency-notifications) .

An updated overview of the UCB=C2=A0SA/NV large shareholdings will be avail=
able on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://ww=
w.ucb.com/investors/UCB-shareholders) .

For further information, contact UCB:

Investor Relation
Antje Witte
T +32 2 559 94 14
antje.witte@ucb.com (mailto:antje.witte@ucb.com)

Corporate Communications
Laurent Schots
T+32 2 559 92 64
=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8Blaurent.scho=
ts@ucb.com (mailto:laurent.schots@ucb.com) =C2=A0=C2=A0=C2=A0=C2=A0=C2=A0

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news

Image
FMR LLC (https://mb.cision.com/Public/18595/3610818/abf09884c5075e09_org.pn=
g) Image
Notified details (https://mb.cision.com/Public/18595/3610818/b07ffbdadf6504=
83_org.png) Image
Chain of controlled undertakings through which the holding is effectively h=
eld (https://mb.cision.com/Public/18595/3610818/817e4c5acee4c837_org.png) G=
enericFile
220805 - PB Transparantieverklaring FMR LLC (https://mb.cision.com/Public/1=
8595/3610818/bd54f6ffefc36555.pdf) GenericFile
220805 - PR Transparency notification FMR LLC (https://mb.cision.com/Public=
/18595/3610818/b081bfb55585e1b4.pdf) GenericFile
220805 - CdP Notification de transparence FMR LLC (https://mb.cision.com/Pu=
blic/18595/3610818/9a5072d795d4cd14.pdf)

______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x112836x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium